The point-of-care device, which predicts severe lung disease in the ICU and NICU, has been CE marked for investigational use

SIME AI device that predicts acute respiratory disease receives CE Mark - changing the standard of care for millions of babies worldwide

The company is now starting a pilot of "RDS Predict," which is the first of several apps that will soon be available on the platform. RDS Predict can tell which babies are most likely to get Respiratory Distress Syndrome (RDS), which is the most common cause of illness and death in premature babies. By predicting RDS at birth, neonatologists will be able to give early and preventative targeted treatment within the first hour of life, which will improve outcomes and save lives.

Read the full article here: prnewswire.co.uk/news-releases